Ciliate and yeast telomerase possess a nucleolytic activity capable of removing DNA from the 3 end of a single-stranded oligonucleotide substrate. The nuclease activity is thought to assist in enzyme proofreading and/or processivity. Herein, we report a previously uncharacterized human telomerase-associated nuclease activity that shares several properties with ciliate and yeast telomerases. Partially purified human telomerase, either from cell extracts or recombinantly produced, demonstrated an ability to remove 3 nontelomeric nucleotides from a substrate containing 5 telomeric DNA, followed by extension of the newly exposed telomeric sequence. This cleavage/extension activity was apparent at more than one position within the telomeric DNA and was influenced by sequences 5 to the telomeric/nontelomeric boundary and by substitution with a methylphosphonate moiety at the telomeric/nontelomeric DNA boundary. Our data suggest that human telomerase is associated with an evolutionarily conserved nucleolytic activity and support a model in which telomerase-substrate interactions can occur distal from the 3 primer end.
INTRODUCTION
Telomeres comprise the repetitive regions of DNA and associated proteins found at chromosomal termini and are essential for genome stability in many eukaryotic organisms (for review, see Blackburn, 2001 ). In most eukaryotes, telomeres are maintained by telomerase, a specialized polymerase that uses an internal RNA component and a reverse transcriptase to copy telomeric sequence, one nucleotide at a time, onto single-stranded telomeric DNA (for review, see Nugent and Lundblad, 1998) . In humans, ciliates, and yeast, the telomerase RNA (TER) subunit and a telomerase reverse transcriptase (TERT) may be minimally sufficient for in vitro elongation of telomeric sequence (Lingner et al., 1997; Weinrich et al., 1997; Beattie et al., 1998; Collins and Gandhi, 1998; Nakayama et al., 1998; Bachand and Autexier, 1999; Masutomi et al., 2000; Wenz et al., 2001) .
In addition to a telomere polymerization activity, ciliate and yeast telomerases also possess an associated nuclease activity (Collins and Greider, 1993; Autexier and Greider, 1994; Cohn and Blackburn, 1995; Melek et al., 1996; Bednenko et al., 1997; Bhattacharyya and Blackburn, 1997; Prescott and Blackburn, 1997; Greene et al., 1998; Lue and Peng, 1998; Niu et al., 2000) . The nucleolytic activity of ciliate telomerase removes nontelomeric DNA that is 3Ј of telomeric sequence, or it may remove a single nucleotide of telomeric DNA aligned at the 5Ј end of the telomerase RNA template (Collins and Greider, 1993; Melek et al., 1996) . The yeast telomerase-associated nuclease is stimulated by primer-template mismatches or noncanonical yeast telomere repeat sequences (Prescott and Blackburn, 1997; Niu et al., 2000) . The nucleolytic activity may be inherent to the telomerase complex because it copurifies with ciliate and yeast telomerase over several steps (Melek et al., 1996; Greene et al., 1998; Niu et al., 2000) . Moreover, the nucleolytic activity associated with Tetrahymena thermophila telomerase can be reconstituted in rabbit reticulocyte lysate (RRL) containing recombinant telomerase RNA and tTERT (Collins and Gandhi, 1998) . Unpurified recombinant human telomerase also generated products shorter-than-input primer length when incubated with a telomeric oligonucleotide (Huard et al., 2003) . The proposed functions of the telomerase nucleolytic activity include proofreading and/or reinitiation of a stalled polymerization complex (Collins and Greider, 1993; Melek et al., 1996) . The telomerase-associated nuclease does not perform the resection of newly synthesized G strand overhangs that occurs at ciliate telomeres, because Tetrahymena cells depleted for telomerase still undergo 3Ј end processing (Jacob et al., 2003) .
In addition to the aforementioned findings, several studies suggest that sequences upstream of the 3Ј primer end can influence substrate utilization and that telomerase-substrate contacts can occur distal to the 3Ј primer end (Harrington and Greider, 1991; Morin, 1991; Collins and Greider, 1993; Lee and Blackburn, 1993; Melek et al., 1996; Bednenko et al., 1997; Wang and Blackburn, 1997; Bottius et al., 1998; Lue and Peng, 1998; Fitzgerald et al., 2001) . One compelling piece of evidence for multiple contacts between telomerase and its substrate is the ability to cross-link Euplotes aediculatus telomerase to two sites within a telomeric oligonucleotide: one at the 3Ј primer end and at a second site 20 nucleotides upstream (Hammond et al., 1997) . These observations are consistent with a two-site recognition model in which telomerase contacts a substrate at the 3Ј end and at a region upstream of the terminus, at a proposed anchor site. The anchor site may promote the association of telomerase with its substrate during translocation, that is, the reiterative translocation of the telomerase RNA template relative to the DNA substrate during processive elongation of the DNA substrate (Harrington and Greider, 1991; Morin, 1991; Collins and Greider, 1993) . Experiments in E. aediculatus indicate that the intervening DNA sequence between the anchor site and the 3Ј terminus may be looped out (Hammond et al., 1997) . It is not known whether the putative anchor site within telomerase contributes to the recognition and cleavage of nontelomeric DNA from substrates.
We have used partially purified human telomerase to determine whether a telomerase-associated nucleolytic activity is conserved in higher eukaryotes. Specifically, we have examined our preparations for an activity that removes 3Ј nontelomeric DNA from 5Ј telomeric sequence. We used chimeric oligonucleotide substrates composed of a 5Ј telomeric region and a 3Ј nontelomeric region to examine the effect of primer length and sequence on cleavage and extension. In addition, the position of cleavage was probed with oligonucleotides containing a nuclease-resistant modification. Finally, we examined the influence of primer sequence on the mode of extension, either by direct elongation of the primer 3Ј end or by cleavage and subsequent elongation.
MATERIALS AND METHODS

Oligonucleotides
Unless otherwise stated, unmodified oligonucleotides were synthesized and cartridge purified by ACGT (Toronto, Ontario, Canada). The methylphosphonate-containing oligonucleotides were synthesized either by TriLink Biotechnologies (San Diego, CA) or by Gene Link (Hawthorne, NY) and gel purified as described previously (Melek et al., 1996) . Primers containing a 3Ј dideoxynucleotide were end-labeled with Tdt (Niu et al., 2000) and gel purified (Melek et al., 1996) as described previously . Gel-purified oligonucleotides were electrophoresed on a 15% (wt/vol) denaturing gel (19:1, acrylamide: bisacrylamide), excised and eluted in TE buffer (10 mM Tris-Cl, pH 7.5, 1 mM EDTA, pH 8.0) overnight. The eluate was then purified over a C18 reverse phase column (Waters, Milford, MA). The column was activated with 100% methanol and preequilibrated with TE. After loading the oligonucleotide, the column was washed with water several times, and the oligonucleotide was eluted with 50% methanol. The oligonucleotide was then lyophilized in a speed vacuum (Savant Instruments, Holbrook, NY) for several hours. The primers were 5Ј end-labeled with [␥- 32 P]ATP (3000 Ci/mmol, 10 mCi/ml; PerkinElmer Life and Analytical Sciences, Boston, MA) and T4 Kinase (Invitrogen, Carlsbad, MA) according to the latter manufacturer's instructions. Approximately 0.2 fmol of end-labeled oligonucleotide was loaded for detection on a denaturing polyacrylamide gel.
Cell Culture and Lysate Preparation
Raji cells were grown in RPMI 1640 media [supplemented with 10% (vol/vol), fetal bovine serum and 1ϫ l-glutamine] in a 100-liter reactor at Amgen (Thousand Oaks, CA), harvested in mid-log phase, washed in phosphatebuffered saline, and frozen in liquid nitrogen. Each frozen pellet of ϳ2 ϫ 10 10 cells was thawed and resuspended in an equal volume of 2.3ϫ hypo buffer (23 mM HEPES, 7 mM KCl, 2.3 mM MgCl 2 ) supplemented with protease inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN), RNase inhibitors (20 U/ml; Roche Diagnostics); and ␤-mercaptoethanol (2 mM). The mixture was subjected to ϳ90 strokes in a Dounce homogenizer by using a loose pestle. Mechanical lysis was performed on ice at 4°C. The lysate was then subjected to centrifugation at 100,000 ϫ g in a SW50.1 rotor (Beckman Coulter, Fullerton, CA) at 4°C for 1 h. The supernatant was removed, adjusted to between 0.1 and 0.15 M NaCl and 20% (vol/vol) glycerol, and snap frozen in liquid nitrogen.
In Vitro Transcription of hTER
hTER was synthesized using a MEGAscript T7 in vitro transcription kit (Ambion) as per manufacturer's instructions (Beattie et al., 1998) . The telomerase RNA was transcribed from the linearized, gel-purified cDNA in the presence of RNase inhibitor (40 U/20-l reaction; Roche Diagnostics) for 4 h at 37°C. The in vitro transcription products were treated with DNase I (2 U/20-l reaction) for 15 min at 37°C. The reaction mixture was then phenol/ chloroform extracted and precipitated at Ϫ20°C. Full-length hTER was obtained by gel purification: the reaction products were electrophoresed on a 4% (wt/vol) polyacrylamide denaturing gel (29:1, acrylamide/bisacrylamide), and UV shadowed at a wavelength of 254 nm. Full-length hTER was excised, eluted in water (1 h at 65°C), and reprecipitated at Ϫ20°C. After centrifugation, the pellet was washed with 70% (vol/vol) ethanol and then resuspended in water.
In Vitro Reconstitution of Human Telomerase
Telomerase was reconstituted in rabbit reticulocyte lysates (RRLs) as described previously (Beattie et al., 1998) . Recombinant hTERT (accession no. NM_003219) was FLAG-tagged at both the amino and carboxyl termini. Full-length FLAG-tagged hTERT was synthesized (2 h at 30°C) in the presence of gel-purified, full-length hTER (0.5 g/50-l reaction) by using a TNT T7-coupled reticulocyte lysate system (Promega, Madison, WI) according to the manufacturer's instructions. After reconstitution, the RRL extract was adjusted to 20% (vol/vol) glycerol, aliquoted, frozen on dry ice, and stored at Ϫ70°C.
Anion Exchange Chromatography
One milliliter of Raji cell lysate was thawed and clarified by centrifugation in a Microfuge for 5 min at 4°C. The supernatant was adjusted to 0.1 M NaCl (if necessary) by dilution with 2.3ϫ hypo buffer (23 mM HEPES, 7 mM KCl, 2.3 mM MgCl 2 ) containing 20% (vol/vol) glycerol, 2 mM ␤-mercaptoethanol, protease inhibitor cocktail tablets (Roche Diagnostics), and RNase inhibitors at 10 U/ml. All subsequent steps were performed at 4°C. A 400-l DEAE column (Bio-Rad, Hercules, CA) was pre-equilibrated with 2.3ϫ hypo buffer adjusted to 0.1 M NaCl and supplemented with RNase and protease inhibitors, glycerol, and ␤-mercaptoethanol as described above. The Raji lysate was passed over the resin three times (ϳ0.1 ml/min) followed by a wash with 5 ml of equilibration buffer. Telomerase was eluted with 2.3ϫ hypo buffer adjusted to 0.3 M NaCl (supplemented as described above). Fractions (400 l) were collected and tested for protein content with a Bradford assay (Bio-Rad). The fraction containing peak amounts of telomerase activity was used in subsequent experiments.
Immunopurification of Recombinant Human Telomerase
Anti-FLAG M2-agarose affinity gel (600 l; Sigma-Aldrich, St. Louis, MO) was equilibrated with 2.3ϫ hypo buffer containing 0.15 M NaCl, 0.1% (wt/vol) CHAPS, 20% (vol/vol) glycerol, 2 mM ␤-mercaptoethanol, protease inhibitor cocktail tablets (Roche Diagnostics), and RNase inhibitors at 10 U/ml. Three milliliters of rabbit reticulocyte lysate containing reconstituted human telomerase was passed over the M2 anti-FLAG resin three times at 4°C, at 0.3 ml/min. The anti-FLAG M2-agarose affinity gel was washed with 15 ml of equilibration buffer containing 0.3 M NaCl, washed again with equilibration buffer (at 0.15 M NaCl), and an aliquot of beads (200 l) was removed from the column. The wash step was repeated with 15 ml of equilibration buffer containing 0.6 M NaCl. The resin was removed from the column and suspended in equilibration buffer adjusted to ϳ0.15 M NaCl.
Standard Elongation Assay/Conventional Telomerase Assay
In a 40-l reaction, 1ϫ SEA buffer (2 mM dATP, 2 mM TTP, 1 mM MgCl 2 , 1 mM spermidine, 5 mM ␤-mercaptoethanol, 50 mM KOAc, 50 mM Tris acetate, pH 8.5), 200 pmol of primer, and 40 Ci of [␣- 32 P]dGTP (800 Ci/mmol, 10 mCi/ml; PerkinElmer Life and Analytical Sciences). According to the source of telomerase, the reaction also included one of the following: 20 l of anion exchange purified telomerase from Raji cells (ϳ100 g of protein), 20 l of rabbit reticulocyte lysate containing reconstituted telomerase, or 10 l of recombinant telomerase captured on anti-FLAG resin. For those samples pretreated with RNase A, 50 g of DNase-free RNase A (Sigma-Aldrich) was added to the sample and incubated at room temperature for 15 min before adding oligonucleotide, buffer, and isotope. For all reactions, the remaining volume was adjusted to 40 l with 2.3ϫ hypo buffer (23 mM HEPES, 7 mM KCl, 2.3 mM MgCl 2 ). The telomerase assays were carried out for 2 h in a 30°C water bath as described previously (Morin, 1989) with the following exceptions: samples containing rabbit reticulocyte lysate were phenol/chloroform extracted twice, and 1 l of GenElute LPA (Sigma-Aldrich) was added to all samples immediately before precipitation (in place of carrier RNA). After precipitation and removal of the supernatant, the pellets were resuspended in 7 l of load dye [80% (vol/vol) formamide, 0.1% (wt/vol) xylene cyanol, 0.6ϫ Tris borate-EDTA (TBE), 10 mM EDTA]. The samples were placed in a heating block at 100°C for 5 min, quick spun and loaded onto a 10 or 12% (wt/vol) denaturing gel (29:1, acrylamide/bisacrylamide, 7 M urea, 0.6ϫ TBE), which was prerun for at least 30 min. The gel was electrophoresed at 1000 -1500 V in 0.6ϫ TBE for ϳ2 h (or until the bromphenol blue in the load dye in an adjacent lane was two-thirds of the way down the gel). The gel was dried for 1 h at 80°C and placed on a phosphor screen (Amersham Biosciences, Piscataway, NJ).
SDS-PAGE
Duplicate samples containing either 2.5 l of RRL (with hTER/hTERT or no DNA) or 10 l of immunopurified telomerase captured onto M2 anti-FLAG resin (Sigma-Aldrich) were suspended in SDS-PAGE load dye and resolved on 4 -12% (wt/vol) gradient SDS-PAGE gels (Invitrogen). One gel was transferred to Immobilon P membrane (Millipore, Billerica, MA) and probed with 0.1 g/ml polyclonal anti-TERT antibody. Another similar gel was silverstained according to a previously described procedure (Wray et al., 1981) .
Antibodies
The anti-hTERT polyclonal rabbit antibody was raised against a HIS-tagged hTERT fragment, spanning amino acids 560 -956, purified from Escherichia coli. The antisera were affinity purified by coupling the same hTERT fragment to Affigel (Bio-Rad) according to the manufacturer's instructions.
RESULTS
A Human Nucleolytic Activity Removes Nontelomeric DNA from the 3 End of Substrates Containing 5 Telomeric Sequence
In the "standard elongation" or conventional human telomerase assay, telomerase elongation products are visualized by the incorporation of [␣- 32 P]dGTP, in the presence of TTP and dATP, onto the 3Ј terminus of a single-stranded DNA oligonucleotide ( Figure 1A , lane 2) (Greider and Blackburn, 1985; Morin, 1989) . This assay possesses several advantages over the more sensitive, polymerase chain reaction-based telomere repeat amplification protocol (Kim et al., 1994) in its ability to directly visualize telomerase extension products. In the standard elongation assay, the six-base periodicity observed in the telomerase extension products reflects product accumulation at the translocation site within the RNA template, which in humans corresponds to the first G in the telomeric repeat TTAGGG (Morin, 1989) . To avoid elongation patterns due to contamination of less than full-length oligonucleotides, all substrates were purified after oligonucleotide synthesis (see MATERIALS AND METHODS). Similar results were obtained with cartridge, high-performance liquid chromatography, or gel-purified oligonucleotides.
Human telomerase was partially purified from Raji cell extracts by anion exchange chromatography. Using this preparation, we examined the telomerase extension products upon incubation with the telomeric substrate (T 2 AG 3 ) 4 ( Figure 1A , lane 2). In a separate reaction, the primer was also 5Ј end-labeled with 32 P to indicate the approximate position of the input oligonucleotide ("I"; Figure 1A , lane 1). As expected, incubation of telomerase with the telomeric substrate (T 2 AG 3 ) 4 generated elongation products ("P") that initiated above the position of the full-length oligonucleotide, denoted PϾI ( Figure 1A , compare lanes 1 and 2), and possessed a periodicity that was consistent with the addition of TTAG, etc. (Morin, 1989) . Products shorter than the input primer (PϽI) also were generated, although these do not possess the periodicity typical of telomerase elongation products (Huard et al., 2003) . All products were sensitive to treatment of the extract with RNase A before incubation with the substrate, confirming that their synthesis was RNA dependent ( Figure 1A , lane 3). The elongation products were ablated by altering the 3Ј-terminal nucleotide to ddGTP ( Figure 1A , lane 5), confirming that the preferential mode of elongation of this telomeric substrate is by extension of the 3Ј primer end (Morin, 1989) . Chimeric oligonucleotides were designed containing telomeric DNA at the 5Ј end and nontelomeric sequence at the 3Ј end. For example, the chimeric oligonucleotide (T 2 AG 3 ) 2 X 12 contains 12 nucleotides of telomeric DNA at the 5Ј primer end, denoted (T 2 AG 3 ) 2 , and 12 nucleotides of fixed nontelomeric sequence at the 3Ј primer end, denoted X 12 (see Table 1 for primer sequence). On incubation with the partially purified human telomerase preparation, the (T 2 AG 3 ) 2 X 12 primer generated products that migrated below the full-length oligonucleotide (denoted PϽI) and possessed a six-base periodicity ( Figure 1B , compare lanes 4 and 5). The extension products of (T 2 AG 3 ) 2 X 12 comigrated with the telomerase extension products generated by incubation with the 5Ј telomeric sequence (T 2 AG 3 ) 2 ( Figure 1B , compare lanes 2 and 5). These observations suggested that the (T 2 AG 3 ) 2 X 12 oligonucleotide was cleaved to (T 2 AG 3 ) 2 before extension by telomerase. Note that a less intense, shorter product was also apparent after incubation with (T 2 AG 3 ) 2 X 12 , suggesting that a minority of oligonucleotide is cleaved at an alternate 5Ј position within the telomeric region of the substrate ( Figure 1B , lane 5, see asterisk). The relatively weaker intensity of the shortest product could be due to one of the following: infrequent utilization of a cleavage site 5Ј to the telomeric/nontelomeric boundary, a reduction in precipitation efficiency or a low dissociation rate of short elongation products (Collins and Greider, 1993) . All products, PϾI or PϽI, were sensitive to treatment of the extract with RNase A before incubation with substrate, confirming that their synthesis was RNA dependent ( Figure 1B , lane 6).
To determine whether the observed elongation products initiated from a position internal to the input primer 3Ј end, the partially purified telomerase preparation was incubated with an identical chimeric oligonucleotide that contained a 3Ј terminal dideoxynucleotide residue. Replacement of the 3Ј terminal nucleotide in (T 2 AG 3 ) 2 X 12 with a dideoxynucleotide (ddTTP) did not ablate formation of PϽI products ( Figure 1B , lane 8). These findings indicate that, unlike extension of (T 2 AG 3 ) 4 , 3Ј terminal sequence is removed from (T 2 AG 3 ) 2 X 12 before elongation by telomerase.
We tested another chimeric oligonucleotide, (G 3 T 2 A) 2 X 9 , that contained a permuted telomeric repeat at the 5Ј end and a shorter 3Ј nontelomeric end. The (G 3 T 2 A) 2 X 9 primer also generated PϽI products ( Figure 1B , lane 14) that were sensitive to pretreatment of the extract with RNase A ( Figure  1B , lane 15). As with (T 2 AG 3 ) 2 X 12 , the PϽI products were unperturbed by replacement of the 3Ј-terminal nucleotide in (G 3 T 2 A) 2 X 9 with a dideoxynucleotide residue (ddTTP); again, consistent with the notion that the PϽI products are generated by cleavage before extension by telomerase (Figure 1B, lane 17) . The (G 3 T 2 A) 2 X 9 PϽI extension products comigrated with the PϾI products of the telomeric sequence (G 3 T 2 A) 2 indicating that cleavage occurred at or near the telomeric/nontelomeric boundary of (G 3 T 2 A) 2 X 9 ( Figure 1B , compare lanes 11 and 14).
In further support of the notion that both of the chimeric oligonucleotides were cleaved at or near the junction between telomeric and nontelomeric DNA, the major products generated by (T 2 AG 3 ) 2 X 12 and (G 3 T 2 A) 2 X 9 are offset from each other as predicted based on the permutation of the telomeric sequence at the primer 5Ј end ( Figure 1B , compare lanes 5 and 14; see Figure 1C for schematic).
We next queried the sequence specificity of the nuclease cleavage activity by examining whether a scrambled 5Ј telomeric sequence would lead to the generation of PϽI products. The chimeric oligonucleotide, (TGAGTG) 2 X 12 , generated only faint PϽI products ( Figure 1B , lane 23) despite the efficient elongation of the scrambled telomeric sequence (TGAGTG) 2 by telomerase ( Figure 1B, lane 20) . This result suggests that the PϽI elongation products are more pronounced when a chimeric oligonucleotide contains telomeric sequence upstream of the 3Ј primer end.
Immunoaffinity-purified Recombinant Telomerase Is Associated with Nucleolytic Activity
The aforementioned data suggest that partially purified human telomerase is associated with an activity that removes nontelomeric DNA from the 3Ј end of a chimeric substrate. As a further demonstration that the observed nucleolytic activity copurifies with telomerase, recombinant hTER and FLAG-tagged hTERT were assembled in rabbit reticulocyte lysates (Weinrich et al., 1997; Beattie et al., 1998) . Recombinant telomerase was captured on anti-FLAG affinity resin and washed with equilibration buffer containing either 0.3 M NaCl or 0.6 M NaCl. Immunopurification of recombinant telomerase enriched for a protein of ϳ120 kDa that comigrated with hTERT by Western analysis (Figure 2A ). This species was absent from mock anti-FLAG purifications Figure 1 . (A) Telomerase elongation products generated by incubation with telomeric substrates. The standard elongation assay was conducted using partially purified human telomerase from Raji cells and an oligonucleotide corresponding to four human telomeric repeats. Products of the standard elongation assay were electrophoresed on a 10% polyacrylamide denaturing gel. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4). Oligonucleotides containing a dideoxynucleotide modification at the 3Ј terminus are indicated by dd (lanes 4 -6). Those samples pretreated with RNase A are indicated above the lane corresponding to their respective telomerase elongation reactions (ϩ; lanes 3 and 6). (B) Telomerase elongation products generated by incubation with substrates containing 5Ј telomeric DNA and 3Ј nontelomeric DNA. The standard elongation assay was conducted using partially purified human telomerase from Raji cells and the indicated oligonucleotide. Primer sequence composition is indicated by color code: black for telomeric DNA, white for nontelomeric DNA and striped for G-rich DNA. See Table 1 for oligonucleotide sequences. Products from the standard elongation assay were resolved on a 10% polyacrylamide sequencing gel. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4, 7, 10, 13, 16, 19, and 22) . Oligonucleotides containing a dideoxynucleotide modification at the 3Ј terminus are indicated by dd (lanes 7-9, 16 -18). Perhaps due to an additional gel purification step, the dideoxynucleotide modified oligonucleotides generated slightly less intense elongation products relative to unmodified substrates (lanes 8 and 17, our unpublished results). Those samples pretreated with RNase A are indicated above the lane corresponding to their respective telomerase elongation reactions (ϩ; lanes 3, 6, 9, 12, 15, 18, 21, and 24 ). An asterisk to the left indicates the position of the shortest product in lane 5. (C) Model for the cleavage and subsequent elongation of (T 2 AG 3 ) 2 X 12 and (G 3 T 2 A) 2 X 9 . Primer sequence composition is indicated by color: black for telomeric DNA and white for nontelomeric DNA. Primers are cleaved to expose telomeric DNA that becomes a substrate for elongation by telomerase (where G represents the incorporation of [␣-32 P]dGTP by telomerase). Note that regardless of whether cleavage occurs 5Ј of or at the telomeric/nontelomeric DNA boundary, the elongation products will be similarly offset due to the permutation of telomeric DNA.
with rabbit reticulocyte lysate alone (our unpublished data). The activity of reconstituted human telomerase was examined in the standard elongation assay (using both rabbit reticulocyte lysates and the immunopurified material). Rabbit reticulocyte lysates containing FLAG-tagged hTERT and hTER demonstrated elongation of the telomeric oligonucleotide (T 2 AG 3 ) 2 ( Figure 2B , lane 8) (Weinrich et al., 1997; Beattie et al., 1998) . Incubation of recombinantly produced human telomerase with the chimeric oligonucleotide (T 2 AG 3 ) 2 X 12 resulted in RNase-sensitive PϽI products that comigrated with those generated by partially purified telomerase from Raji cells ( Figure 2B , compare lanes 5 and 11). Purified recombinant telomerase (washed in 0.3 M NaCl) was also active when incubated with the telomeric oligonucleotide (T 2 AG 3 ) 2 and exhibited PϽI products when incubated with the chimeric substrate (T 2 AG 3 ) 2 X 12 ( Figure 2B , lanes 14 and 17). The PϽI products observed with (T 2 AG 3 ) 2 X 12 comigrated with those generated by partially purified telomerase from Raji cells and were RNase-sensitive ( Figure 2B , compare lanes 5 with 17 and lanes 17 with 18). Higher stringency washing (at 0.6 M NaCl) did not alter or reduce the PϽI products generated by incubation of affinity-purified recombinant telomerase with (T 2 AG 3 ) 2 X 12 ( Figure 2B , lane 23). These findings indicate that human telomerase synthesized in rabbit reticulocyte lysates is associated with a nucleolytic activity.
As a demonstration that the nuclease activity was associated with human telomerase under alternate purification conditions, endogenous telomerase was isolated by gel filtration chromatography or antisense affinity selection (Schnapp et al., 1998; our unpublished data) . Similar PϽI products were obtained upon incubation of the chimeric oligonucleotide (T 2 AG 3 ) 2 X 12 with telomerase purified by anion exchange chromatography, gel filtration chromatography, or antisense affinity selection (our unpublished data).
Length Modulation of the Telomeric and Nontelomeric Regions within Chimeric Oligonucleotides
To further characterize the PϽI products from the chimeric oligonucleotides, the length of the telomeric or nontelomeric region was varied within the substrate (while keeping the length and sequence of the other region constant). The chimeric oligonucleotides (T 2 AG 3 ) 2 X 36 and (T 2 AG 3 ) 2 X 12 possess the same 5Ј telomeric DNA but differ in length by 24 nucleotides at the nontelomeric 3Ј end (see Table 1 for primer sequence). Thus, if cleavage occurred in both substrates at or near the junction of telomeric and nontelomeric DNA, the resultant PϽI elongation products should exhibit the same elongation pattern despite the difference in length and sequence of the cleaved 3Ј fragments. Indeed, this prediction was borne out ( Figure 3A , compare lanes 8 and 11). The PϽI products generated by both (T 2 AG 3 ) 2 X 12 and (T 2 AG 3 ) 2 X 36 comigrated with the elongation products generated by incubation with (T 2 AG 3 ) 2 ( Figure 3A, lane 2) . The length of the 5Ј telomeric region also was varied. The oligonucleotides (G 3 T 2 A) 2 X 9 and TA(G 3 T 2 A) 2 X 9 differ in their 5Ј telomeric sequence by two nucleotides but possess a nontelomeric region of the same length and sequence (see Table 1 for primer sequence). The PϽI products generated upon incubation with the primer TA(G 3 T 2 A) 2 X 9 initiated at a position that differed by approximately two nucleotides relative to those of (G 3 T 2 A) 2 X 9 ( Figure 3B , compare lanes 2 and 5). In comparison, the oligonucleotide (G 3 T 2 A) 3 X 9 contains an additional six nucleotides of telomeric sequence at the 5Ј end relative to (G 3 T 2 A) 2 X 9 . Interestingly, the PϽI products generated by (G 3 T 2 A) 3 X 9 initiated at the same position as those generated by (G 3 T 2 A) 2 X 9 , despite a length difference in the 5Ј telomeric region of the oligonucleotides ( Figure 3B , compare lanes 2 and 8, see arrow at right), which supports the notion that cleavage can occur 5Ј of the telomeric/ nontelomeric DNA boundary. Identical results to those shown in Figure 3 also were obtained with immunoaffinitypurified recombinant human telomerase (our unpublished data).
A Nuclease-resistant Methylphosphonate Substitution Alters Substrate Utilization in a Position-specific Manner
Methylphosphonate modification was used to further examine the location of cleavage within the chimeric oligonucleotide substrates. By replacing the nonbridging oxygen of a phosphodiester bond with a methyl group, the linkage is rendered nuclease resistant (Stein and Cohen, 1988) . If the modified site corresponds to a unique cleavage site, the reaction products will be altered relative to those from an unmodified oligonucleotide. For example, a chimeric oligonucleotide containing a methylphosphonate substitution at the boundary between telomeric and nontelomeric DNA inhibits the generation of PϽI products upon incubation with Euplotes crassus telomerase (Melek et al., 1996; Bednenko et al., 1997) . TA(G 3 T 2 A) 2 CGCGATACT (G 3 T 2 A) 3 X 9 (G 3 T 2 A) 3 CGCGATACT (G 3 T 2 A) 2 X 5 ⅐ X 4 (G 3 T 2 A) 2 CGCGA ⅐ TACT (G 3 T 2 A) 2 ⅐ X 9 (G 3 T 2 A) 2 ⅐ CGCGATACT (T 2 AG 3 ) 2 X 6 ⅐ X 6 (T 2 AG 3 ) 2 CTACGC ⅐ GATACT (T 2 AG 3 ) 2 ⅐ X 12 (T 2 AG 3 ) 2 ⅐ CTACGCGATACT Ϫ12/Ϫ25 GGAGGTGGGTGGGG Ϫ3/Ϫ25 GGAGGTGGGTGGGGCGAGCAGAG TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 TA(G 3 T 2 A) 2 CGAGCAGAG Ϫ12/Ϫ25X 9 GGAGGTGGGTGGGGCGCGATACT a Where " ⅐ " indicates a methylphosphonate linkage.
After incubation with partially purified telomerase from cells, (G 3 T 2 A) 2 X 9 generated PϽI products as observed previously ( Figure 4A , lane 2; see bracket at right). (Note that the oligonucleotides used in Figure 4 were gel purified and generated fewer products in the standard elongation assay relative to cartridge-purified oligonucleotides used in other experiments). The chimeric substrate (G 3 T 2 A) 2 X 9 was modified within the nontelomeric region generating the oligonucleotide (G 3 T 2 A) 2 X 5 ⅐X 4 (where ⅐ indicates a methylphosphonate linkage; see Table 1 for primer sequence). Incubation with (G 3 T 2 A) 2 X 5 ⅐X 4 resulted in PϽI products similar to those generated with the unmodified oligonucleotide (G 3 T 2 A) 2 X 9 ( Figure 4A, compare lanes 2 and 5) . This result indicates that methylphosphonate modification of the phosphodiester bond 4 nucleotides from the primer 3Ј end does not prevent substrate binding or elongation. Because methylphosphonate substitution in the nontelomeric region would be expected to prevent formation of PϽI products generated by an exonuclease, we speculate that an endonuclease is responsible for the cleavage activity, as described for the E. crassus telomerase-associated nuclease (Melek et al., 1996) . Next, the effect of modification at the boundary between 5Ј telomeric and 3Ј nontelomeric DNA was examined with the oligonucleotide (G 3 T 2 A) 2 ⅐X 9 . In contrast with (G 3 T 2 A) 2 X 5 ⅐X 4 , incubation with (G 3 T 2 A) 2 ⅐X 9 resulted in alteration but not inhibition of product formation relative to the unmodified oligonucleotide (G 3 T 2 A) 2 X 9 ( Figure 4A , compare lanes 2, 5, with 8). Incubation with (G 3 T 2 A) 2 ⅐X 9 resulted in formation of both PϽI and PϾI products that were sensitive to pretreatment with RNase A ( Figure 4A, compare lanes 8 and 9) .
Similar results were obtained with modified versions of the chimeric substrate (T 2 AG 3 ) 2 X 12 . A primer containing a methylphosphonate substitution in the nontelomeric region, (T 2 AG 3 ) 2 X 6 ⅐X 6 , did not inhibit or alter product formation relative to the unmodified oligonucleotide (T 2 AG 3 ) 2 X 12 (Figure 4B , compare lanes 5 and 8, see arrow at right; see Table  1 for primer sequence). The effect of modification at the boundary between the 5Ј telomeric and the 3Ј nontelomeric DNA was examined with the oligonucleotide (T 2 AG 3 ) 2 ⅐X 12 . Methylphosphonate modification at the telomeric/nontelomeric DNA junction altered but did not ablate product formation by human telomerase relative to the unmodified oligonucleotide (T 2 AG 3 ) 2 X 12 ( Figure 4B , compare lanes 5 and 11); in fact, both PϽI and PϾI reaction products seemed more abundant relative to those generated by (T 2 AG 3 ) 2 X 12 or (T 2 AG 3 ) 2 X 6 ⅐X 6 ( Figure 4B , compare lanes 5 with 11 and 8 with 11). Replacement of the 3Ј terminal nucleotide in (T 2 AG 3 ) 2 ⅐X 12 with a ddTTP residue did not ablate formation of PϽI products ( Figure 4B, lane 14) . The reduction in overall efficiency of product formation may be due to an additional gel-purification step required to produce the dideoxymodified version of (T 2 AG 3 ) 2 ⅐X 12 ( Figure 4B , compare lanes 11 and 14). Therefore, we could not conclude whether the PϾI products resulting from incubation with (T 2 AG 3 ) 2 ⅐X 12 are generated by extension of a 5Ј cleavage product or by direct elongation of the nontelomeric 3Ј end.
The persistence of PϽI products upon introduction of a methylphosphonate linkage at the telomeric/nontelomeric junction suggests that cleavage occurred elsewhere in the oligonucleotides (G 3 T 2 A) 2 ⅐X 9 and (T 2 AG 3 ) 2 ⅐X 12 (i.e., 5Ј of the boundary) or via an alternate nucleolytic mechanism that was not inhibited by methylphosphonate modification. Methylphosphonate substitutions 5Ј of the telomeric/nontelomeric border were not examined because such modifications can impair elongation when in proximity to a 3Ј terminus capable of direct extension by ciliate telomerase (Shippen, personal communication) . In addition to cleavage within the telomeric region, cleavage also may occur at the boundary between telomeric and nontelomeric DNA. The appearance of PϾI products after incubation with (G 3 T 2 A) 2 ⅐X 9 and (T 2 AG 3 ) 2 ⅐X 12 (and not their counterparts modified in the 3Ј nontelomeric region) suggests that methylphosphonate modification at the telomeric/nontelomeric boundary does affect substrate utilization. Therefore, cleavage of (G 3 T 2 A) 2 ⅐X 9 and (T 2 AG 3 ) 2 ⅐X 12 likely occurs at various positions, including sites 5Ј of or at the junction between telomeric and nontelomeric DNA.
Primer Sequence Composition Influences the Mode of Substrate Utilization
We next examined the contribution of the 3Ј nontelomeric end to the cleavage and elongation of the chimeric DNA substrates. We tested the elongation properties of a chimeric oligonucleotide possessing complementarity to the telomerase RNA template at the 3Ј primer end, to determine whether such a substrate would promote direct elongation of the primer 3Ј end and perhaps interfere with the generation of PϽI products. We used the chromosome 16 breakpoint sequence associated with the (␣␣) TI determinant of ␣-thalassemia (Wilkie et al., 1990) . The terminally truncated chromosome is "healed" in vivo by the addition of telomeric sequence (Wilkie et al., 1990) . Furthermore, the breakpoint sequence was shown to be a substrate for direct addition (i.e., direct extension of the primer 3Ј end) by human and ciliate telomerases in vitro (Harrington and Greider, 1991; Morin, 1991) . The Ϫ3/Ϫ25 primer encodes the sequence immediately upstream of one possible breakpoint junction (at the Ϫ3 position) and is a substrate for human telomerase in the standard elongation assay (Morin, 1991 ) (see also Figure 5A , lane 5; refer to Figure 5B for schematic). Two features promote utilization of the Ϫ3/Ϫ25 oligonucleotide by telomerase: a G-rich region at the 5Ј end similar to telomeric DNA (designated Ϫ12/Ϫ25) and a 3Ј region (Ϫ3/ Ϫ11) able to pair with two to four nucleotides of the telomerase RNA template (Morin, 1991) . The G-rich region at the 5Ј end is thought to associate with the telomerase anchor site, whereas the nucleotides at the 3Ј end allow minimal pairing to occur with the RNA template, thus fulfilling the "two-site" criteria for telomerase binding (Harrington and Greider, 1991; Morin, 1991) .
In comparison with the Ϫ3/Ϫ25 oligonucleotide, the chimeric substrate TA(G 3 T 2 A) 2 X 9 generated distinct PϽI products, indicating that it was cleaved before extension by telomerase ( Figure 5A , lane 11; see also Figure 3B , lane 5). We replaced the nine nontelomeric residues of TA(G 3 T 2 A) 2 X 9 with nine nucleotides of 3Ј sequence from the Ϫ3/Ϫ25 oligonucleotide. Since the resultant oligonucleotide, TA(G 3 T 2 A) 2 Ϫ3/Ϫ11, contains 3Ј sequence capable of limited pairing with the telomerase RNA template, we asked whether this modified substrate would still support the generation of PϽI products (see Figure  5B for primer sequence and schematic). We found that TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 generated both PϽI and PϾI products ( Figure 5A, compare lanes 7 and 8) . Notably, TA(G 3 T 2 A) 2 Ϫ3/ Ϫ11 and TA(G 3 T 2 A) 2 X 9 , which share the same 5Ј telomeric sequence, produced comigrating PϽI elongation products (Figure 5, compare lanes 8 and 11) . Furthermore, oligonucleotides TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 and Ϫ3/Ϫ25, which share the same 3Ј sequence, generated similar PϾI products ( Figure 5 , compare lanes 5 and 8). The dual pattern of products resulting from incubation with TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 suggests that this chimeric oligonucleotide can be elongated either after removal of 3Ј sequence or by direct extension of the 3Ј terminus ( Figure 5B) .
Interestingly, when the 5Ј telomeric sequence of TA(G 3 T 2 A) 2 X 9 was replaced with a G-rich sequence corre- Figure 2 . Elongation products generated upon incubation with immunoaffinity-purified recombinant human telomerase. (A) Silver stain of an SDS-PAGE gel containing samples loaded as follows: 2.5 l of rabbit reticulocyte lysate containing hTER and FLAG-tagged hTERT (RRL, lane 1), 10 l of immunopurified recombinant telomerase washed with buffer containing 0.3 M NaCl (␣-FLAG 0.3M, lane 2), or 0.6 M NaCl (␣-FLAG 0.6M, lane 3). The protein enriched by immunopurification is indicated to the left with an arrow. Duplicate samples were electrophoresed on an SDS-PAGE gel, transferred to a membrane, and probed with anti-hTERT antibody. The order of samples is as follows: 2.5 l of rabbit reticulocyte lysate containing no DNA (Ϫve, lane 1) or hTER and FLAG-tagged hTERT (RRL, lane 2), 10 l of immunopurified recombinant telomerase washed with buffer containing 0.3 M NaCl (␣-FLAG 0.3M, lane 3), or 0.6 M NaCl (␣-FLAG 0.6 M, lane 4). The sponding to the 5Ј region of Ϫ3/Ϫ25, the resulting primer (Ϫ12/Ϫ25X 9 ) generated faint, albeit RNase A-sensitive PϽI products ( Figure 5A , compare lanes 14 and 15; see Table 1 for primer sequence). As observed previously with an oligonucleotide containing a G-rich (rather than telomeric) sequence at the 5Ј end of the chimeric oligonucleotide, elongation of Ϫ12/Ϫ25X 9 resulted in less distinct products ( Figure 1B, lane 23) . Furthermore, the PϽI products generated upon incubation with Ϫ12/Ϫ25X 9 did not comigrate with the PϾI products from extension of the G-rich 5Ј sequence Ϫ12/Ϫ25 ( Figure 5A, compare lanes 2 and 14) . These data suggest that Ϫ12/Ϫ25X 9 is not cleaved at the boundary between the Ϫ12/Ϫ25 sequence and the X 9 sequence, but rather elsewhere within the primer.
DISCUSSION
We have described a nucleolytic activity associated with partially purified endogenous and recombinant human telomerase. This study extends previous reports of a telomerase-associated nucleolytic activity in ciliates and yeast (Melek et al., 1996; Greene et al., 1998; Niu et al., 2000) by demonstrating that the nuclease activity robustly purifies with recombinant telomerase components ( Figure 2B ). Earlier reports indicated that a nucleolytic activity is present in unpurified rabbit reticulocyte preparations containing reconstituted telomerase (Collins and Gandhi, 1998; Huard et al., 2003) . In the present study, detection of a nucleolytic activity relied on elongation of a cleaved chimeric substrate by telomerase. Thus far, we have been unable to develop a nucleolytic cleavage assay that is independent of elongation activity. However, the copurification of human telomerase with the nucleolytic activity argues in favor of a coupled cleavage/elongation process, rather than one in which telomerase extends nonspecifically degraded oligonucleotides in the reaction mixture.
Characteristics of the Human Telomerase-associated Nuclease Activity
The human telomerase-associated nuclease activity removes nontelomeric DNA from the 3Ј terminus of substrates containing upstream G-rich (or telomeric) DNA. PϽI products consistent with the removal (before elongation) of up to 36 nucleotides of nontelomeric DNA from the 3Ј primer end were observed ( Figure 3A, lane 8) . Similarly, E. crassus telomerase can eliminate at least 29 nucleotides of nontelomeric DNA from the 3Ј terminus of a chimeric oligonucleotide (Greene et al., 1998) . The resulting 5Ј primer fragment is the substrate for subsequent extension by human telomerase because a dideoxynucleotide modification at the 3Ј end of a chimeric oligonucleotide did not block the formation of PϽI products, also consistent with the properties of E. crassus telomerase (Melek et al., 1996 ; this study). In keeping with this notion, PϽI product formation was sensitive to changes in telomeric register of the 5Ј telomeric DNA ( Figure 1B) .
The cleavage and extension of chimeric substrates also was influenced by divergence from canonical telomeric sequence at the 5Ј primer end. Replacement of 5Ј telomeric sequence with G-rich sequence or noncanonical telomeric repeats, resulted in less pronounced PϽI products ( Figures  1B and 5) . The indistinct pattern of products generated by (TGAGTG) 2 X 12 and Ϫ12/Ϫ25X 9 may be due to inefficient or nonuniform elongation of G-rich and noncanonical telomeric sequences. Alternatively, resection of (TGAGTG) 2 X 12 and Ϫ12/Ϫ25X 9 may be less efficient if the nucleolytic activity is sequence specific. Sequence specificity may be conferred by the template region of the RNA subunit, which has been implicated in the cleavage activity associated with both yeast and ciliate telomerases (Collins and Greider, 1993; Prescott and Blackburn, 1997; Greene et al., 1998) .
Length variation within the 5Ј telomeric region by using (G 3 T 2 A) 2 X 9 and (G 3 T 2 A) 3 X 9 indicated that cleavage can occur 5Ј of or at the telomeric/nontelomeric boundary. Flexibility of the cleavage position also was observed upon incubation with methylphosphonate-modified oligonucleotides. Elongation products generated by (G 3 T 2 A) 2 X 9 and (T 2 AG 3 ) 2 X 12 were altered but not inhibited by position-specific methylphosphonate modification at the boundary between telomeric and nontelomeric sequence. Although position-specific methylphosphonate modification inhibited product formation by E. crassus telomerase (Melek et al., 1996; Bednenko et al., 1997) , the results from ciliate and human telomerase may not be directly comparable because the methylphosphonate substitutions were placed at different positions within the species-specific telomeric register and the oligonucleotides contained different lengths of 5Ј telomeric sequence. In fact, flexible cleavage site positioning has been observed in E. crassus telomerase by using unmodified chimeric oligonucleotides (Greene et al., 1998) . Furthermore, Saccharomyces cerevisiae telomerase can use an alternate cleavage site when the preferred site is blocked by a methylphosphonate linkage (Niu et al., 2000) .
Other data also suggest that telomerase may be capable of flexible substrate utilization. We found that alteration of the 3Ј primer end to allow limited pairing with the telomerase RNA template (as with TA(G 3 T 2 A) 2 Ϫ3/Ϫ11) resulted in a dual pattern of PϽI and PϾI products suggestive of direct and cleavage-mediated extension ( Figure 5 ). Ciliate telomerase also may directly elongate or cleave and extend telomeric primers containing a mismatched nucleotide at the 3Ј end (Collins and Greider, 1993) .
Sequences Distal from the Primer 3 Terminus Can Affect Substrate Utilization
Our findings indicate that sequences upstream from the 3Ј terminus can influence substrate utilization by telomerase. Furthermore, the ability of telomerase to cleave an oligonucleotide at an upstream site does not depend on recognition of the 3Ј terminus of the DNA substrate. Substrate recognition by telomerase both at the 3Ј primer end and at an upstream site has been reported for telomerases from various organisms, including humans (Har- Figure 2 (cont). molecular mass (in kilodaltons) of protein markers is indicated at right. A longer exposure was performed to allow detection of hTERT synthesized in rabbit reticulocyte lysates (bottom; see lane 2). (B) Standard elongation assays were conducted with one of the following: 20 l of partially purified telomerase from Raji cells (Raji DEAE, lanes 2, 3, 5, and 6), 20 l of rabbit reticulocyte lysate containing hTER and FLAG-tagged hTERT (RRL lysate, lanes 8, 9, 11, and 12), 10 l of immunopurified recombinant telomerase washed with buffer containing 0.3 M NaCl lanes 14, 15, 17, and 18), lanes 20, 21, 23, and 24) . Primer sequence is indicated above the corresponding lane: telomeric DNA is represented in black and nontelomeric DNA in white. The products resulting from incubation with (T 2 AG 3 ) 2 are shown in lanes 2, 3, 8, 9, 14, 15, 20, and 21 . The products arising from incubation with (T 2 AG 3 ) 2 X 12 are shown in lanes 5, 6, 11, 12, 17, 18, 23, and 24. See Table 1 for oligonucleotide sequence. The products were resolved on a 12% polyacrylamide sequencing gel. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of the corresponding telomerase elongation reactions (I; lanes 1, 4, 7, 10, 13, 16, 19, and 22) . Pretreatment with RNase A is indicated (ϩ) for the samples corresponding to lanes 3, 6, 9, 12, 15, 18, 21, and 24. rington and Greider, 1991; Morin, 1991; Collins and Greider, 1993; Lee and Blackburn, 1993; Melek et al., 1996; Bednenko et al., 1997; Hammond et al., 1997; Wang and Blackburn, 1997; Bottius et al., 1998; Lue and Peng, 1998; Fitzgerald et al., 2001) . The 5Ј recognition site may be positioned at varying distances from the 3Ј terminus. Regardless of whether the 3Ј sequences are extended directly or cleaved before elongation, telomerase can use substrates that contain 29 -36 nucleotides of nontelomeric DNA at the primer 3Ј end (Harrington and Greider, 1991; Melek et al., 1996; Greene et al., 1998 ; this study). An upper limit for the length of intervening nontelomeric DNA has not been determined. Telomerase might contact its substrate at the 3Ј terminus and at a spatially distant upstream site by looping out the intervening DNA (Harrington and Greider, 1991; Morin, 1991) . The loop-out Figure 3 . Telomerase elongation products generated by incubation with chimeric oligonucleotides containing different lengths of 3Ј nontelomeric or 5Ј telomeric DNA. The standard elongation assay was conducted using partially purified human telomerase from Raji cells and the oligonucleotide indicated above each lane: black for telomeric DNA, white for nontelomeric DNA. Refer to Table 1 for oligonucleotide sequences. (A) Utilization of chimeric oligonucleotides with varying lengths of 3Ј nontelomeric DNA. The standard elongation assay products were resolved on a 10% polyacrylamide sequencing gel. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4, 7, and 10). RNase A pretreatment is indicated by ϩ above the corresponding lane (lanes 3, 6, 9, and 12). Note that the products in the upper region of lane 8 were not RNase A sensitive (lane 9) and are therefore not telomerase dependent (see asterisk beside this region in the gel). (B) Utilization of chimeric oligonucleotides with varying lengths of 5Ј telomeric DNA. Products generated in the standard elongation assay were electrophoresed on a 12% polyacrylamide denaturing gel.
32 P-5Ј end-labeled primers are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4, and 7). RNase A pretreatment is indicated by ϩ above the corresponding lane (lanes 3, 6, and 9). The shortest major product generated by incubation with (G 3 T 2 A) 2 X 9 and (G 3 T 2 A) 3 X 9 is indicated by an arrow at right (lanes 2 and 8). Note that the products in the upper section of lanes 2, 5, and 8 were not sensitive to treatment with RNase A (lanes 3, 6, and 9, respectively) and are therefore not telomerase dependent.
model is supported by cross-linking analysis in E. aediculatus. Contact between E. aediculatus telomerase and a telomeric primer occurs at two sites spaced eight nucleotides apart on the telomerase RNA subunit and 20 nucleotides apart on the oligonucleotide substrate (Hammond et al., 1997) .
Possible Roles for the Nucleolytic Activity of Human Telomerase
Detection of a telomerase-associated nuclease in ciliates, yeast, and humans suggests that this activity has an evolutionarily conserved function rather than a species-specific role related to developmentally programmed chromosome Table 1 . Products from the standard elongation assay were resolved on a 10% polyacrylamide sequencing gel. All oligonucleotides used in these experiments were subjected to gel purification. (A) Elongation of the primer (G 3 T 2 A) 2 X 9 containing methylphosphonate substitutions. Lanes 1-3, (G 3 T 2 A) 2 X 9 ; lanes 4 -6, (G 3 T 2 A) 2 X 5 ⅐X 4 primer modified with a methylphosphonate linkage within the 3Ј nontelomeric DNA; lanes 7-9, (G 3 T 2 A) 2 ⅐X 9 primer modified with a methylphosphonate linkage at the telomeric/ nontelomeric DNA boundary. The PϽI products generated by the chimeric oligonucleotides are indicated by a bracket at right. Note that the products in the upper region of lane 2 were not RNase A sensitive (compare with lane 3) and did not occur in all experiments. However, the PϾI products in lane 8 were sensitive to RNase A treatment (compare with lane 9). Input oligonucleotides were 32 P-5Ј end-labeled for reference (I; lanes 1, 4, and 7). Samples pretreated with RNase A are designated above by ϩ (lanes 3, 6, and 9). (B) Elongation of the primer (T 2 AG 3 ) 2 X 12 containing methylphosphonate substitutions. Lanes 1-3, (T 2 AG 3 ) 2 ; lanes 4 -6, (T 2 AG 3 ) 2 X 12 ; lanes 7-9, (T 2 AG 3 ) 2 X 6 ⅐X 6 primer modified with a methylphosphonate linkage in the 3Ј nontelomeric DNA; lanes 10 -12, (T 2 AG 3 ) 2 ⅐X 12 primer modified with a methylphosphonate residue at the telomeric/nontelomeric DNA boundary; lanes 13-15, (T 2 AG 3 ) 2 ⅐X 12 containing a methylphosphonate residue at the telomeric/nontelomeric DNA boundary and a terminal dideoxy TTP. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4, 7, 10, and 13). Sample pretreatment with RNase A is represented above the respective lanes (ϩ; lanes 3, 6, 9, 12, and 15). An arrow to the right indicates the position of the PϽI product generated by the chimeric oligonucleotides. RNase A-insensitive products are observed in lanes 5, 6, 8, 9, 11, and 12. RNase A-sensitive PϾI products were generated by incubation with (T 2 AG 3 ) 2 ⅐X 12 (lane 11). Figure 5 . Telomerase elongation products generated by oligonucleotides containing 3Ј sequence that is partially complementary to the telomerase RNA template. (A) Standard elongation assay was conducted using partially purified human telomerase from Raji cells and the oligonucleotide indicated above each lane: black for telomeric DNA, white for nontelomeric DNA, and striped for G-rich DNA. Refer to Table  1 for oligonucleotide sequences. Standard elongation assay products were resolved on a 10% acrylamide sequencing gel. The 32 P-5Ј end-labeled input oligonucleotides are shown to the left of their respective telomerase elongation reactions (I; lanes 1, 4, 7, 10, and 13). Those samples pretreated with RNase A are indicated above the corresponding lane (ϩ; lanes 3, 6, 9, 12, and 15). RNase A-insensitive products are indicated by an asterisk alongside the gel (lanes 5 and 6). (B) Schematic for the direct elongation of Ϫ3/Ϫ25 and the proposed utilization of TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 by human telomerase. The Ϫ3/Ϫ25 primer is composed of a G-rich 5Ј region (denoted Ϫ12/Ϫ25) and a 3Ј region capable of limited pairing with the telomerase RNA template (denoted Ϫ3/Ϫ11) (Morin, 1991) . As previously shown, the Ϫ3/Ϫ25 primer can be directly extended by human telomerase (Morin, 1991) . Potential base pairing with the telomerase RNA template is indicated above the primer sequence and the newly synthesized telomeric DNA is underlined. Both Ϫ3/Ϫ25 and TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 possess the same 3Ј sequence (designated Ϫ3/Ϫ11). Therefore, TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 may participate in 3Ј primer-template base-pairing interactions as with Ϫ3/Ϫ25. The PϾI extension products generated by TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 may result from the direct extension of this oligonucleotide by telomerase. The telomeric sequence at the 5Ј end of TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 may promote cleavage and subsequent extension by telomerase, consistent with the PϽI products observed with this primer. The 5Ј product of cleavage at the telomeric/nontelomeric boundary in TA(G 3 T 2 A) 2 Ϫ3/Ϫ11 is shown (although cleavage may also occur 5Ј of the boundary). fragmentation (in ciliates) or a nonprocessive, nondissociative telomerase activity (in budding yeast). We speculate, as have others, that the telomerase-associated nuclease activity may serve a proofreading function and/or prevent stalling of the telomerase complex (Collins and Greider, 1993; Melek et al., 1996; Greene et al., 1998; Niu et al., 2000) . By analogy, RNA polymerase has an intrinsic endonuclease activity thought to be located at or near the enzyme active site (Fish and Kane, 2002) . The nucleolytic activity of RNA polymerase is stimulated by the cofactors GreA and GreB in prokaryotes and TFIIS in eukaryotes (Fish and Kane, 2002) . This complex can relieve an arrested polymerase by cleaving back the nascent transcript. Stalling of RNA polymerase can occur during transcription of a particular sequence or due to nucleotide misincorporation. The fidelity of human telomerase is critical since alteration of the template region of hTER by a single nucleotide correlates with decreased cell viability (Marusic et al., 1997) . Similarly, substitution of a single nucleotide within the human telomeric repeat prevents association with the telomere binding protein, TRF1 (Zhong et al., 1992) . Removal of nontelomeric DNA from the 3Ј end of a telomeric tract might thus prevent incorporation of incorrect sequence at the growing telomere. The error rate of human telomerase is estimated at 2 ϫ 10 Ϫ3 per nucleotide (Kreiter et al., 1995) . The telomerase-associated nucleolytic activity is unlikely to be the sole determinant of telomere repeat fidelity because human and ciliate telomerase can directly extend primers that contain 3Ј nontelomeric residues (Morin, 1989; Harrington and Greider, 1991; Collins and Greider, 1993 ; this study).
The nuclease activity also may facilitate reinitiation of telomerase elongation, for example, during translocation when the 3Ј end of the DNA substrate is repositioned with respect to the template region of the telomerase RNA. In T. thermophila, removal of a single nucleotide of telomeric sequence has been observed when primer alignment extends to the extreme 5Ј end of the RNA template, where translocation must occur before another round of template-mediated telomere addition (Collins and Greider, 1993) . Further studies will be required to determine whether the nuclease activity associated with human telomerase also can remove a single nucleotide from the 3Ј terminus of a telomeric primer that aligns with the 5Ј end of the hTER template.
Note added in proof. Huard and Autexier have also recently reported that human telomerase is associated with a nucleolytic cleavage activity, and that 3Ј terminal nucleotides can be removed from a telomeric primer (Huard, S., and Autexier, C. [2004] . Human telomerase catalyzes nucleolytic primer cleavage. Nucl. Acids Res. 32, 2171 Res. 32, -2180 
